Apollo Medical appoints Weili Dai and J. Lorraine Estradas to board effective Dec 31, 2021
Astrana Health, Inc.
Weili Dai (co-founder Marvell Technology, MeetKai) and J. Lorraine Estradas (CEO of Arroyo Vista Family Health Center) appointed to board, effective Dec 31, 2021.
Dai brings tech/AI expertise; Estradas adds LA healthcare community leadership and FQHC experience.
Arroyo Vista paid ApolloMed subsidiary ~$1.2M for management services in 9 months ended Sep 30, 2021 (related-party disclosure).
No family relationships or arrangements between the new directors and existing officers/directors.
On December 19, 2021, the Board of Directors (the “Board”) of Apollo Medical Holdings, Inc. (the “Company”) appointed Weili Dai and J. Lorraine Estradas, R.N., B.S.N., M.P.H. to serve as members of the Board, effective December 31, 2021.
On December 19, 2021, the Board of Directors (the “Board”) of Apollo Medical Holdings, Inc. (the “Company”) appointed Weili Dai and J. Lorraine Estradas, R.N., B.S.N., M.P.H. to serve as members of the Board, effective December 31, 2021.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Weili Dai was appointed as Director at Astrana Health, Inc..
Action
appointed
Role
Director
Exact text from the filing
On December 19, 2021, the Board of Directors (the “Board”) of Apollo Medical Holdings, Inc. (the “Company”) appointed Weili Dai and J. Lorraine Estradas, R.N., B.S.N., M.P.H. to serve as members of the Board, effective December 31, 2021.
J. Lorraine Estradas was appointed as Director at Astrana Health, Inc..
Action
appointed
Role
Director
Exact text from the filing
On December 19, 2021, the Board of Directors (the “Board”) of Apollo Medical Holdings, Inc. (the “Company”) appointed Weili Dai and J. Lorraine Estradas, R.N., B.S.N., M.P.H. to serve as members of the Board, effective December 31, 2021.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.